Skip to results

Keyword or reference number

Keyword or reference number

Deferred date

Deferred date

Guidance programme (1 selected)

Guidance programme

Showing 1 to 2 of 2

Deferred
TitleDeferred IDGuidance programmeDeferred date
Ciltacabtagene autoleucel for treating relapsed and lenalidomide-refractory multiple myeloma after 1 to 3 therapies [D5]D5Technology appraisal guidance
Teprotumumab for treating thyroid eye disease [ID6432]D1Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All